Zhen Lu

10PUBLICATIONS
51CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 10, 2026
Inhibition of SIK2 and SIK3 induces adaptive ER-phagy and creates a therapeutic vulnerability in ovarian cancer.

|Jun 12, 2026
Targeting SIK2 with GRN-300 Potentiates Paclitaxel Efficacy in Triple-Negative Breast Cancer.

|Aug 27, 2025
DIRAS3 Inhibits Ovarian Cancer Cell Growth by Blocking the Fibronectin-Mediated Integrin β1/FAK/AKT Signaling Pathway.

Jing Guo, Janice M Santiago-O'Farrill, Vivian Orellana

|Jan 21, 2025
CA-125 as a Biomarker in Renal Medullary Carcinoma: Integrated Molecular Profiling, Functional Characterization, and Prospective Clinical Validation.

Sandra L Grimm, Menuka Karki, Kyle A Blum

|May 23, 2024
Crizotinib Enhances PARP Inhibitor Efficacy in Ovarian Cancer Cells and Xenograft Models by Inducing Autophagy.

Janice M Santiago-O'Farrill, Alicia Blessing Bollu, Hailing Yang

|Jan 03, 2024
DIRAS3 induces autophagy and enhances sensitivity to anti-autophagic therapy in KRAS-driven pancreatic and ovarian carcinomas.

Gamze Bildik, Joshua P Gray, Weiqun Mao

Pageof 2

Frequent Collaborators

8 joint publications

Robert C Bast

3 joint publications

Janice M Santiago-O'Farrill

3 joint publications

Gamze Bildik

2 joint publications

Ranran Wu